Navigation Links
Aware, Inc. Announces Support for New ITU Testing Standard with Line Diagnostics Platform
Date:11/11/2009

m a wide range of competitors; current economic conditions, including the credit crisis affecting the financial markets; our intellectual property is subject to limited protection; our ability to obtain or enforce patents could be affected by new laws, regulations or rules; and our business may be affected by government regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of customers; there has been and may continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies to install DSL service in volume; our test and diagnostic hardware and software products could have quality problems; we depend on a single source contract manufacturer for the manufacture of our DSL hardware products; and we are dependent on single source suppliers for components in our DSL hardware products. Biometric factors include, but are not limited to: market acceptance of our biometric technologies and products; changes in contracting practices of government or law enforcement agencies; the failure of the biometrics market to experience continued growth; announcements or introductions of new technologies or products by our competitors; failures or problems in our biometric software products; delays in the adoption of new industry biometric standards; growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver service contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 200
'/>"/>
SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Aware, Inc. Reports Third Quarter 2009 Financial Results
2. Aware, Inc. Reports Third Quarter 2009 Financial Results
3. Aware, Inc. Reports Second Quarter 2009 Financial Results
4. Aware, Inc. Announces Q209 Earnings Conference Call
5. Aware, Inc. Reports First Quarter 2009 Financial Results
6. Aware, Inc. Reports First Quarter 2009 Financial Results
7. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
8. Aware, Inc. Announces Q1 09 Earnings Conference Call
9. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
10. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
11. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- Den 10. internationale konference om Genomik (ICG-10, ... 25. oktober i Shenzhen , Kina. ... år. Siden starten i 2006 er ICB blevet en ... er en af de mest dynamiske, entusiastiske og sjove ... gennembrud og fremskridt inden for ,omik,-forskning, som yderligere vil ...
(Date:7/31/2015)... , 31 de julho de 2015 ... www.icg-10.org ) será realizada pela BGI de 22-25 de ... . A conferência está celebrando seu 10 ... 2006, a ICG se tornou uma das reuniões mais ... dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... de julio de 2015 La 10 th ... por medio de BGI del 22 al 25 de octubre de ... Este año, la conferencia celebra su décimo aniversario. Desde ... en una de las reuniones anuales más influyentes del mundo ... reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... regularly vomiting hairballs or refusing to eat probably isn,t being ... There is a good chance that the cat is acting ... environment, new research suggests. Healthy cats were just as ... and leave waste outside their litter box in response to ...
... Salt Lake City, December 30, 2010Officials at Huntsman ... that the National Cancer Institute (NCI) has renewed its ... recognizes the outstanding cancer research conducted at HCI, which ... West and is the only NCI-designated Cancer Center within ...
... can result in long waiting times for seriously ill ... illnesses for the next available treatment. In this edition ... Int 2010; 107[50]: 892𔃆), Michael Christ and his ... assessment of emergency patients. Triage provides reliable methods ...
Cached Biology News:Even healthy cats act sick when their routine is disrupted 2Even healthy cats act sick when their routine is disrupted 3Even healthy cats act sick when their routine is disrupted 4Even healthy cats act sick when their routine is disrupted 5National Cancer Institute renews Cancer Center designation for Huntsman Cancer Institute 2
(Date:9/2/2015)... 2015 Research and Markets ( ... Jain PharmaBiotech,s new report "Nanobiotechnology Applications, ... An increasing use of ... is anticipated. Nanotechnology will be applied at ... formulations for optimal delivery to diagnostic applications ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Companies" to their offering. This ... as a characteristic that can be objectively measured ... or pathogenic processes as well as pharmacological responses ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... , September 2, 2015 BiondVax Pharmaceuticals ... the National Institute of Allergy and Infectious Diseases (NIAID), part ... Department of Health and Human Services (HHS), to launch a ... the United States in the 2015-16 timeframe. The ... candidate, Multimeric-001 (M-001), as a primer vaccine, which would be ...
Breaking Biology Technology:Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 2Global Nanobiotechnology Applications, Markets and Companies Report 2015-2024 3Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 2Updated 2015 Biomarkers Report - Latest Technologies, Markets and Companies Insights to 2024 with over 1,000 References 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... SHANGHAI, June 21 /PRNewswire-Asia/ -- WuXi ... pharmaceutical, biotechnology, and medical device research and,development outsourcing company ... that Wei-Min Chang has been appointed Vice President of,Operations ... located in the Jinshan chemical industry zone of Shanghai. ...
... Inc. announced on June 16, 2009, that the Company ... each filed a voluntary petition for reorganization under chapter ... United States Bankruptcy Court for the District of Delaware ... to continue to manage and operate their business as ...
... Corp. (TSX, FSE: HBP) today announced that Dr. Heman ... be presenting a scientific poster describing L-DOS47 analytical method ... Scientists ("AAPS") National Biotechnology Conference, which runs from June ... Trade Center in Seattle, Washington. , ...
Cached Biology Technology:WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 2Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 2Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 5
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: